NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald Allen WilliamsDirector2026-01-165,000$1.67
$8.36kBuy
Donald Allen WilliamsDirector2026-01-095,000$1.88
$9.40kBuy

1 of 1

PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr1.33%1,986,304$3.44MInsider
Regional Medical Center Yuma1.22%1,814,375$3.14MInsider
Princeton Capital Corp0.87%1,293,814$2.24MInsider
Stanley Westreich0.80%1,193,281$2.06MInsider
Karl Johe0.62%930,373$1.61MInsider
Robert J. Trenschel0.21%315,399$545.64kInsider
Sandford D. Smith0.15%219,916$380.45kInsider
John Conron0.08%115,492$199.80kInsider
Catherine A. Sohn0.07%106,952$185.03kInsider
Scott Varde Ogilvie0.06%86,020$148.81kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI0.08%5.55%Net BuyingNet Buying
STTK57.50%23.46%Net BuyingNet Selling
AVTX15.86%84.14%Net SellingNet Selling
NGNE46.19%53.81%Net Selling
CLLS11.49%0.00%

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 0.08% institutional shareholders, 5.55% Palisade Bio insiders, and 94.36% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 1.33% of the company. Richard Garr's Palisade Bio shares are currently valued at $3.46M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.